{"product_id":"global-nuclear-medicine-imaging-agents-supply-demand-and-key-producers-2023-2029","title":"Global Nuclear Medicine Imaging Agents Supply, Demand and Key Producers, 2023-2029","description":"\u003cp\u003eGlobal Nuclear Medicine Imaging Agents Supply, Demand and Key Producers, 2023-2029\u003cbr\u003e\nThe global Nuclear Medicine Imaging Agents market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).\u003c\/p\u003e\n\n\u003cp\u003eThis report studies the global Nuclear Medicine Imaging Agents production, demand, key manufacturers, and key regions.\u003c\/p\u003e\n\n\u003cp\u003eThis report is a detailed and comprehensive analysis of the world market for Nuclear Medicine Imaging Agents, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Nuclear Medicine Imaging Agents that contribute to its increasing demand across many markets.\u003c\/p\u003e\n\n\u003cp\u003eHighlights and key features of the study\u003c\/p\u003e\n\n\u003cp\u003eGlobal Nuclear Medicine Imaging Agents total production and demand, 2018-2029, (K Units)\u003c\/p\u003e\n\n\u003cp\u003eGlobal Nuclear Medicine Imaging Agents total production value, 2018-2029, (USD Million)\u003c\/p\u003e\n\n\u003cp\u003eGlobal Nuclear Medicine Imaging Agents production by region \u0026amp; country, production, value, CAGR, 2018-2029, (USD Million) \u0026amp; (K Units)\u003c\/p\u003e\n\n\u003cp\u003eGlobal Nuclear Medicine Imaging Agents consumption by region \u0026amp; country, CAGR, 2018-2029 \u0026amp; (K Units)\u003c\/p\u003e\n\n\u003cp\u003eU.S. VS China: Nuclear Medicine Imaging Agents domestic production, consumption, key domestic manufacturers and share\u003c\/p\u003e\n\n\u003cp\u003eGlobal Nuclear Medicine Imaging Agents production by manufacturer, production, price, value and market share 2018-2023, (USD Million) \u0026amp; (K Units)\u003c\/p\u003e\n\n\u003cp\u003eGlobal Nuclear Medicine Imaging Agents production by Type, production, value, CAGR, 2018-2029, (USD Million) \u0026amp; (K Units)\u003c\/p\u003e\n\n\u003cp\u003eGlobal Nuclear Medicine Imaging Agents production by Application production, value, CAGR, 2018-2029, (USD Million) \u0026amp; (K Units).\u003c\/p\u003e\n\n\u003cp\u003eThis reports profiles key players in the global Nuclear Medicine Imaging Agents market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GE HealthCare, Bracco Diagnostic, Guerbet, Mallinckrodt, Lantheus, Yantai Dongcheng, Foshan Rui Diao Pharmaceutical, Cardinal Health and Blue Earth Diagnostics, etc.\u003c\/p\u003e\n\n\u003cp\u003eThis report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.\u003c\/p\u003e\n\n\u003cp\u003eStakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Nuclear Medicine Imaging Agents market.\u003c\/p\u003e\n\n\u003cp\u003eDetailed Segmentation:\u003c\/p\u003e\n\n\u003cp\u003eEach section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) \u0026amp; (K Units) and average price (US$\/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.\u003c\/p\u003e\n\n\u003cp\u003eGlobal Nuclear Medicine Imaging Agents Market, By Region:\u003cbr\u003e\nUnited States\u003cbr\u003e\nChina\u003cbr\u003e\nEurope\u003cbr\u003e\nJapan\u003cbr\u003e\nSouth Korea\u003cbr\u003e\nASEAN\u003cbr\u003e\nIndia\u003cbr\u003e\nRest of World\u003c\/p\u003e\n\n\u003cp\u003eGlobal Nuclear Medicine Imaging Agents Market, Segmentation by Type\u003cbr\u003e\nFluorine 18 Labeling\u003cbr\u003e\nCarbon 11 Labeling\u003cbr\u003e\nNitrogen 13 Labeling\u003cbr\u003e\nOxygen 15 Labeling\u003cbr\u003e\nTechnetium 99 Labeling\u003cbr\u003e\nOthers\u003c\/p\u003e\n\n\u003cp\u003eGlobal Nuclear Medicine Imaging Agents Market, Segmentation by Application\u003cbr\u003e\nEarly Diagnosis\u003cbr\u003e\nClinical Stage\u003cbr\u003e\nTreatment Evaluation\u003c\/p\u003e\n\n\u003cp\u003eCompanies Profiled:\u003cbr\u003e\nGE HealthCare\u003cbr\u003e\nBracco Diagnostic\u003cbr\u003e\nGuerbet\u003cbr\u003e\nMallinckrodt\u003cbr\u003e\nLantheus\u003cbr\u003e\nYantai Dongcheng\u003cbr\u003e\nFoshan Rui Diao Pharmaceutical\u003cbr\u003e\nCardinal Health\u003cbr\u003e\nBlue Earth Diagnostics\u003cbr\u003e\nBayer AG\u003cbr\u003e\nAbx Advanced Biochemical\u003cbr\u003e\nEli Lilly and Company\u003cbr\u003e\nJubilant Pharma Limited\u003cbr\u003e\nNavidea\u003c\/p\u003e\n\n\u003cp\u003eKey Questions Answered\u003c\/p\u003e\n\n\u003cp\u003e1. How big is the global Nuclear Medicine Imaging Agents market?\u003c\/p\u003e\n\n\u003cp\u003e2. What is the demand of the global Nuclear Medicine Imaging Agents market?\u003c\/p\u003e\n\n\u003cp\u003e3. What is the year over year growth of the global Nuclear Medicine Imaging Agents market?\u003c\/p\u003e\n\n\u003cp\u003e4. What is the production and production value of the global Nuclear Medicine Imaging Agents market?\u003c\/p\u003e\n\n\u003cp\u003e5. Who are the key producers in the global Nuclear Medicine Imaging Agents market?\u003c\/p\u003e\n\n\u003cp\u003e6. What are the growth factors driving the market demand?\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"July, 2023 \/ 109 Pages \/ MCW16237491","offer_id":47652476649778,"sku":null,"price":5376.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-nuclear-medicine-imaging-agents-supply-demand-and-key-producers-2023-2029","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}